Stocks and Investing Stocks and Investing
Fri, April 21, 2023

Jasper Hellweg Maintained (UTHR) at Strong Buy with Decreased Target to $280 on, Apr 21st, 2023


Published on 2024-10-28 02:55:59 - WOPRAI, Jasper Hellweg
  Print publication without navigation


Jasper Hellweg of Argus Research, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Decreased Target from $300 to $280 on, Apr 21st, 2023.

Jasper has made no other calls on UTHR in the last 4 months.



There are 4 other peers that have a rating on UTHR. Out of the 4 peers that are also analyzing UTHR, 0 agree with Jasper's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Jasper


  • Ashwani Verma of "UBS" Maintained at Strong Buy with Decreased Target to $310 on, Monday, April 10th, 2023
  • Terence Flynn of "Morgan Stanley" Maintained at Buy with Decreased Target to $316 on, Monday, April 10th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, February 23rd, 2023
  • Jessica Fung of "JP Morgan" Maintained at Buy with Increased Target to $280 on, Thursday, February 23rd, 2023

Contributing Sources